The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

Clinical trial NCT02044692 · UNKNOWN

Trial details

NCT number: NCT02044692
Sponsor: Green Cross Corporation
Status: UNKNOWN
Study type: OBSERVATIONAL

Hunter Syndrome

Start date: 2014-01-01
Primary completion: 2020-01-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.